Simeon John George
Independent DirectorDr. Simeon John George, M.B.A., M.D., is an Independent Director of ADARx Pharmaceuticals, Inc. since July 2021. is a Director of CRISPR Therapeutics, Inc since April 2015. He is CEO of SR One Capital Read Less Simeon George. Dr. George serves as a Co-Founder, Chief Executive Officer and Managing Partner at SR One Capital Management, LP since September 2020. He joined the SR One Capital Management, LP in 2007. He focuses on West Coast. He was CEO & Partner of SR One Capital Management, LP from 2019 to 2022. He was Partner of SR One Capital Management, LP from 2007 to 2019. Dr. George was formerly a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. He is Independent Director of CRISPR Therapeutics AG from April 2015. Dr. George serves as a Director at Avenzo Therapeutics, Inc. He joined the CRISPR Therapeutics AG in April 2015. He served as Director of Rezo Therapeutics Inc. He is Director of Bird Rock Bio, Inc. Previously, Dr. George was the Chief Executive Officer and President of S.R. One, Limited, called GSK Equity Investments, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc, where he had been employed since 2007. In 2003 and 2004 he was an investment banker at Merrill Lynch and Goldman Sachs. He was Independent Non-Executive Director of Turning Point Therapeutics, Inc. from May 2017 to August 15, 2022. He was Independent Director of Nkarta, Inc. from February 2020 to 2026. He is Director of Simcha Therapeutics Holding Company, LLC from January 27, 2022. He is Independent Director of Design Therapeutics, Inc. from February 2020 and serves as its Lead Independent Director since August 25, 2023. He was Director of Genocea Biosciences, Inc. He was employed at Genocea Biosciences, Inc. from February 2009 to December 12, 2014. He was Director of HTG Molecular Diagnostics, Inc. He was employed at HTG Molecular Diagnostics, Inc. from June 2011 to October 27, 2015. He was Director of SEMPRUS BioSciences, Corp. He was Director of Progyny, Inc. from May 2012 to October 2019. He was employed at Progyny, Inc. from June 05, 2012 to October 2019. He was Independent Director of Principia Biopharma Inc. from January 2011 to September 28, 2020. He was employed at Principia Biopharma Inc. until September 28, 2020. He was Director of eFFECTOR Therapeutics, Inc. He has B.A. in Neuroscience from Johns Hopkins University, M.B.A. from University of Pennsylvania - The Wharton School, M.D. from Perelman School of Medicine at the University of Pennsylvania.
Positions
- Company NameADARx Pharmaceuticals, Inc.Stock CodeADRXPositionIndependent DirectorColleagues
- LZLi ZhenCo-Founder, President, CEO & Director
- ECErez ChimovitsInterim Independent Chairman
- ARA. Robert MacLeodChief Scientific Officer
- RFRyan FiskCFO & Chief Business Officer
- CCChristopher ClaeboeSenior Vice President of Operations
- RZRui ZhuChief Technology Officer
- CLCarl Lee GordonIndependent Director
- YHYing HuangIndependent Director
